NATR vs. VSTM, VRCA, NUS, CMRX, FBIO, BRLS, YGF, TTCF, BRLSW, and SNAXW
Should you be buying Nature's Sunshine Products stock or one of its competitors? The main competitors of Nature's Sunshine Products include Verastem (VSTM), Verrica Pharmaceuticals (VRCA), Nu Skin Enterprises (NUS), Chimerix (CMRX), Fortress Biotech (FBIO), Borealis Foods (BRLS), YanGuFang International Group (YGF), Tattooed Chef (TTCF), Borealis Foods (BRLSW), and Stryve Foods (SNAXW).
Nature's Sunshine Products (NASDAQ:NATR) and Verastem (NASDAQ:VSTM) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, media sentiment, profitability, earnings, risk and community ranking.
Nature's Sunshine Products has higher revenue and earnings than Verastem. Verastem is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.
In the previous week, Verastem had 5 more articles in the media than Nature's Sunshine Products. MarketBeat recorded 5 mentions for Verastem and 0 mentions for Nature's Sunshine Products. Verastem's average media sentiment score of 0.62 beat Nature's Sunshine Products' score of 0.00 indicating that Verastem is being referred to more favorably in the news media.
79.4% of Nature's Sunshine Products shares are held by institutional investors. Comparatively, 88.4% of Verastem shares are held by institutional investors. 4.7% of Nature's Sunshine Products shares are held by insiders. Comparatively, 2.9% of Verastem shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Nature's Sunshine Products has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500. Comparatively, Verastem has a beta of 0.48, indicating that its share price is 52% less volatile than the S&P 500.
Verastem received 433 more outperform votes than Nature's Sunshine Products when rated by MarketBeat users. Likewise, 65.20% of users gave Verastem an outperform vote while only 62.89% of users gave Nature's Sunshine Products an outperform vote.
Nature's Sunshine Products presently has a consensus target price of $24.00, indicating a potential upside of 28.41%. Verastem has a consensus target price of $28.79, indicating a potential upside of 175.99%. Given Verastem's higher probable upside, analysts plainly believe Verastem is more favorable than Nature's Sunshine Products.
Nature's Sunshine Products has a net margin of 3.39% compared to Verastem's net margin of 0.00%. Nature's Sunshine Products' return on equity of 12.25% beat Verastem's return on equity.
Summary
Nature's Sunshine Products beats Verastem on 9 of the 17 factors compared between the two stocks.
Get Nature's Sunshine Products News Delivered to You Automatically
Sign up to receive the latest news and ratings for NATR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NATR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Nature's Sunshine Products Competitors List
Related Companies and Tools
